Drug profile · INN
triamcinolone acetonide
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide (TRIAMCINOLONE ACETONIDE) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: dental. Current US regulatory status: approved.
Drug details — triamcinolone acetonide
- US status
- approved
- Class
- —
- Route
- DENTAL
- Patents
- 0
- Programs
- 9
- Data quality
- 0.89
Quick answer
triamcinolone acetonide (TRIAMCINOLONE ACETONIDE) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: dental. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is triamcinolone acetonide?
triamcinolone acetonide (TRIAMCINOLONE ACETONIDE) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: dental. Current US regulatory status: approved.
What is the brand name for triamcinolone acetonide?
TRIAMCINOLONE ACETONIDE is a marketed brand name for triamcinolone acetonide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of triamcinolone acetonide?
triamcinolone acetonide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.